Breaking News, Financial News

Financial Report: WuXi PharmaTech

Lab services up 13% in the quarter

WuXi PharmaTech

1Q Revenues: $131.9 Million (+12%)

1Q Earnings: $21.7 million (+3%)

Comments: Laboratory services grew 13% to $97.5 million in the quarter with China-based lab services up 16% to $74.5 million, and U.S. services up 4% to $23.0 million. Manufacturing services revenue grew 10% to $34.4 million.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters